Energesis Pharmaceuticals, Inc.
PrivateLast Round
Grant
Sep 1, 2021
Total Funding Raised
$5.55M
Company Overview
Energesis Pharmaceuticals, Inc. is a biotechnology company that develops therapeutic drugs for the treatment of obesity, diabetes, and related metabolic diseases by leveraging brown adipose tissue biology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Energesis Pharmaceuticals, Inc. Comparables
Compare Energesis Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adipo Therapeutics | 86% | |
| Eolo Pharma | 86% | |
| Brite Therapeutics | 85% |
Energesis Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2021 | ||||
| Grant | Sep 30, 2019 | ||||
| Grant | May 27, 2015 | ||||
| Accelerator | Oct 1, 2010 |
Energesis Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Massachusetts Life Sciences Center | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| MassChallenge Israel | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2025
Grew 100% QoQ from 3 to 6 employees.
- Sep 1, 2021
$1M grant from National Institute of Diabetes and Digestive and Kidney Diseases.
Energesis Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Energesis Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is Energesis Pharmaceuticals, Inc. a public or private company?
Energesis Pharmaceuticals, Inc. is a private company.
What is the current stock price of Energesis Pharmaceuticals, Inc.?
Energesis Pharmaceuticals, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Energesis Pharmaceuticals, Inc. worth (valuation)?
Valuation information for Energesis Pharmaceuticals, Inc. is not publicly available.
Can I buy Energesis Pharmaceuticals, Inc. stock?
Energesis Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Energesis Pharmaceuticals, Inc.'s last funding round?
Energesis Pharmaceuticals, Inc.'s most recent funding round was Grant on September 1, 2021.
Who are the main investors in Energesis Pharmaceuticals, Inc.?
Key investors in Energesis Pharmaceuticals, Inc. include Massachusetts Life Sciences Center, National Institute of Diabetes and Digestive and Kidney Diseases, MassChallenge.
Will Energesis Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for Energesis Pharmaceuticals, Inc..
How can I track Energesis Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Energesis Pharmaceuticals, Inc.'s secondary market activity and sign up for updates.